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Following publication of the original article \[[@CR1]\], the authors reported an error. The incorrect sex-specific incidences of GCA were published. The correct mean annual cumulative incidence was 22.0 (95% CI 20.6--23.5) for women and 10.5 (95% CI 9.5--11.5) for men; *p*-value \< 0.001 unaffected by the error. Revised versions of Fig. [2](#Fig1){ref-type="fig"} and Table [2](#Tab1){ref-type="table"} are provided in this correction. Additionally, in the results section (page 4, first section) we report results of a sub-analysis of an extended cohort (*n* = 881). The correct annual cumulative incidence for women in this group was 24.1 and for men 11.6.Fig. 2Annual cumulative incidence of giant cell arteritis (American College of Rheumatology (ACR) criteria fulfilled) in Bergen health area 1972--2012. Overall and ESR-specific cumulative incidence calculated as cases per 100,000 general population over the age of 50 years. Incidence by sex was calculated per 100,000 women or men, respectively, and incidence by the different age categories was calculated per 100,000 population of the same age categories (\< 60 years, 60--69 years, 70--79 years and 80+ years). Points plotted represent raw incidence. Solid lines were estimated using the smoothing technique of a moving average of 5 years. ESR, erythrocyte sedimentation rateTable 2The incidence of giant cell arteritis (GCA) in Bergen health area 1972--2012a Mean annual cumulative incidenceAll time1972--19921993--2012Cumulative incidence95% CICumulative incidence95% CICumulative incidence95% CIAll patients16.7(15.5, 18.0)11.2(9.8, 12.7)22.5(20.5, 24.7)Sex Female22.0(20.6, 23.5)13.3(11.8, 14.9)31.2(28.8, 33.7) Male10.5(9.5, 11.5)8.6(7.4, 9.9)12.4(10.9, 14.0)Age, years  \< 602.8(2.3, 3.3)1.5(1.0, 2.1)4.1(3.3, 5.0) 60--6915.5(14.4, 16.8)10.9(9.6, 12.4)20.3(18.4, 22.4) 70--7934.5(32.8, 36.4)23.4(21.4, 25.6)46.2(43.3, 49.2) 80+26.8(25.3, 28.4)14.3(12.8, 16.0)39.9(37.2, 42.7)ESR, mm/hr ESR \< 858.2(7.3, 9.1)4.5(3.7, 5.5)12.0(10.6, 13.6) ESR \> 858.4(7.6, 9.3)6.6(5.5, 7.7)10.4(9.0, 11.8)b Relative risk (RR) according to time, sex, age and ESR1972--19921993--2012RR95% CIp-valueRR95% CIp-valueUnadjusted Time (years)1.1(1.1, 1.1)\< 0.0011.0(1.0, 1.0)0.543Sex Time (years)1.1(1.1, 1.1)\< 0.0011.0(1.0, 1.0)0.462 Sex (Male vs. Female)0.6(0.5, 0.8)\< 0.0010.4(0.3, 0.5)\< 0.001Age Time (years)1.1(1.1, 1.1)\< 0.0011.0(1.0, 1.0)0.135 60--69 vs. \< 607.2(5.1, 10.6)\< 0.0015.0(3.9, 6.4)\< 0.001 70--79 vs. \< 6015.4(11.0, 22.5)\< 0.00111.3(9.1, 14.3)\< 0.001 80+ vs. \< 609.5(6.7, 13.9)\< 0.0019.8(7.8, 12.4)\< 0.001ESR Time (years)1.1(1.1, 1.1)\< 0.0011.0(1.0, 1.0)0.632 ESR (\>median vs. \<median)1.4(1.1, 1.9)0.0060.9(0.7, 1.0)0.116Overall and ESR-specific cumulative incidence reported as cases per 100,000 background population over the age of 50 years. Incidence for sex reported per 100,000 women or men respectively, and incidence for the different age categories reported per 100,000 population of the same age categories (\< 60 years, 60--69 years, 70--79 years and 80+ years). Relative risk calculated according to Poisson regression models for the two timeperiods 1972--1992 and 1993--2012*ESR* Erythrocyte sedimentation rate*CI* Confidence interval
